$SSII
SS Innovations International, Inc. Stock $ssii

$ssii Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024076570 Filed on September 06, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue		$4.386M	$1.575M
YoY Change		178.42%
Cost Of Revenue	$2.106M	$3.346M	$1.351M
YoY Change	65.84%	147.61%	1930.88%
Gross Profit	$1.303M	$1.040M	$224.2K
YoY Change	714.97%	364.17%	-436.94%
Gross Profit Margin		23.72%	14.23%
Selling, General & Admin	$1.735M	$3.777M	$1.983M
YoY Change	36.08%	90.49%	1815.99%
% of Gross Profit	133.19%	363.05%	884.64%
Research & Development	$1.300M	$30.07K
YoY Change	343.64%
% of Gross Profit	99.81%	2.89%
Depreciation & Amortization		$333.9K	$308.6K
YoY Change		8.18%	13435.96%
% of Gross Profit		32.09%	137.68%
Operating Expenses	$7.239M	$3.808M	$1.983M
YoY Change	239.48%	92.0%	1066.3%
Operating Profit	-$5.936M	-$2.767M	-$1.759M
YoY Change	200.95%	57.32%	643.53%
Interest Expense		$2.00	-$91.53K
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$183.3K	-$164.8K	-$91.53K
YoY Change	1497.07%	80.02%	-315731.03%
Pretax Income		-$2.932M	-$1.850M
YoY Change		58.44%	988.48%
Income Tax
% Of Pretax Income
Net Earnings	-$6.119M	-$2.930M	-$1.850M
YoY Change	208.45%	58.34%	988.48%
Net Earnings / Revenue		-66.8%	-117.46%
Basic Earnings Per Share	-$0.04	-$0.02	$0.00
Diluted Earnings Per Share	-$0.04	-$0.02	$0.00
COMMON SHARES
Basic Shares Outstanding	170.7M shares	170.7M shares	146.2M shares
Diluted Shares Outstanding	170.8M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.455M	$423.1K
YoY Change		243.85%	62.04%
Cash & Equivalents	$220.4K	$1.455M	$423.1K
Short-Term Investments
Other Short-Term Assets	$1.311M	$10.12M	$1.383M
YoY Change	-81.41%	631.61%	60309.17%
Inventory	$9.190M	$6.443M	$2.608M
Prepaid Expenses
Receivables	$5.103M	$4.604M	$1.070M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$26.66M	$22.62M	$5.485M
YoY Change	37.95%	312.42%	1982.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.078M	$2.024M	$436.5K
YoY Change	214.07%	363.6%	2635.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.778K	$4.659M
YoY Change
Total Long-Term Assets	$11.15M	$15.69M	$4.208M
YoY Change	135.64%	272.97%	26271.21%
TOTAL ASSETS
Total Short-Term Assets	$26.66M	$22.62M	$5.485M
Total Long-Term Assets	$11.15M	$15.69M	$4.208M
Total Assets	$37.81M	$38.32M	$9.693M
YoY Change	57.16%	295.3%	3370.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.854M	$1.295M	$31.76K
YoY Change	954.64%	3977.47%	-43.17%
Accrued Expenses		$4.273M	$2.131M
YoY Change		100.52%	10193.86%
Deferred Revenue	$982.1K
YoY Change
Short-Term Debt		$12.16M	$6.188M
YoY Change		96.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$18.94M	$17.73M	$8.372M
YoY Change	128.31%	111.73%	3678.11%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$3.609M	$500.0K
YoY Change		621.84%
Total Long-Term Liabilities	$4.979M	$3.609M	$500.0K
YoY Change		621.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.94M	$17.73M	$8.372M
Total Long-Term Liabilities	$4.979M	$3.609M	$500.0K
Total Liabilities	$23.92M	$21.33M	$8.872M
YoY Change	188.32%	140.48%	3903.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.90M	-$32.01M	-$19.10M
YoY Change	98.72%	67.57%	118.85%
Common Stock	$17.09K	$17.07K	$14.62K
YoY Change	-99.95%	16.82%	283.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.89M	$16.98M	$821.6K
YoY Change
Total Liabilities & Shareholders Equity	$37.81M	$38.32M	$9.693M
YoY Change	57.16%	295.3%	3370.13%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$6.119M	-$2.930M	-$1.850M
YoY Change	208.45%	58.34%	988.48%
Depreciation, Depletion And Amortization		$333.9K	$308.6K
YoY Change		8.18%	13435.96%
Cash From Operating Activities		-$3.433M	-$10.34M
YoY Change		-66.81%	6451.67%
INVESTING ACTIVITIES
Capital Expenditures		$171.0K	$736.0K
YoY Change		-76.76%
Acquisitions
YoY Change
Other Investing Activities		$259.7K	$1.228M
YoY Change		-78.86%
Cash From Investing Activities		$88.65K	$492.5K
YoY Change		-82.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		3.500M	9.825M
YoY Change		-64.37%	13530.04%
NET CHANGE
Cash From Operating Activities		-3.433M	-10.34M
Cash From Investing Activities		88.65K	492.5K
Cash From Financing Activities		3.500M	9.825M
Net Change In Cash		156.2K	-25.49K
YoY Change		-712.79%	-70.28%
FREE CASH FLOW
Cash From Operating Activities		-$3.433M	-$10.34M
Capital Expenditures		$171.0K	$736.0K
Free Cash Flow		-$3.604M	-$11.08M
YoY Change		-67.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity File Number EntityFileNumber	000-56608
	dei	Entity Registrant Name EntityRegistrantName	SS INNOVATIONS INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3478854
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Udyog Vihar, Phase III
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2448918	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Address Line1 EntityAddressAddressLine1	405, 3rd Floor
	dei	Entity Address Address Line2 EntityAddressAddressLine2	iLabs Info Technology Centre
	dei	Entity Address City Or Town EntityAddressCityOrTown	Gurugram, Haryana
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	122016
	dei	Entity Address Country EntityAddressCountry	IN
	dei	City Area Code CityAreaCode	+91
	dei	Local Phone Number LocalPhoneNumber	73375 53469
	dei	Security12b Title Security12bTitle	None
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	170739381	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1454675	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2022276	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	5619490	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5029650	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4603800	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1901244	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	6443067	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6447131	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4501398	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3890017	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	22622430	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	19290319	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2023645	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706405	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2448918	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2657554	usd
CY2024Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	5265908	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2365013	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	327012	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	35919	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	4332081	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	4322444	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	15694975	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11654894	usd
CY2024Q2	us-gaap	Assets Assets	38317405	usd
CY2023Q4	us-gaap	Assets Assets	30945213	usd
CY2024Q2	us-gaap	Bank Overdrafts BankOverdrafts	7707534	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	4450000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	428705	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	396784	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1295003	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901550	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3844064	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	577040	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17725305	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7894300	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2125906	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2351113	usd
CY2024Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	544122	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	544122	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	939150	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	939150	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3609178	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3834385	usd
CY2024Q2	us-gaap	Liabilities Liabilities	21334483	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11728685	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2657554	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	428705	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	396784	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2125906	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2351113	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2554611	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2747897	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3658372	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1103760	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2554611	usd
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170738194	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170738194	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170710694	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170710694	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	17073	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17071	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q2	ssii	Translation Adjustment TranslationAdjustment	378165	usd
CY2023Q4	ssii	Translation Adjustment TranslationAdjustment	374087	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	48455054	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45104889	usd
CY2024Q2	ssii	Capital Reserves CapitalReserves	899917	usd
CY2023Q4	ssii	Capital Reserves CapitalReserves	899917	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32010958	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26431263	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	16982922	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	19216528	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38317405	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30945213	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	3345560	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1351143	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7499849	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2351347	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1040491	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	224163	usd
	us-gaap	Gross Profit GrossProfit	4117163	usd
	us-gaap	Gross Profit GrossProfit	735339	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30068	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	426118	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3777479	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1983053	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9102278	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3400013	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	3807546	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1983053	usd
	us-gaap	Operating Expenses OperatingExpenses	9528396	usd
	us-gaap	Operating Expenses OperatingExpenses	3400014	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2767056	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1758890	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5411234	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2664675	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	229521	usd
	us-gaap	Interest Expense Other InterestExpenseOther	399004	usd
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	64741	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	127600	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-91533	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	102943	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-173791	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-164778	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-91533	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-168461	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-173791	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2931834	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1850423	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5579695	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2838466	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2931834	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1850423	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5579695	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2838466	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170738204	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133791407	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170738204	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98172406	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2931834	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1850423	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5579695	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2838466	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1689	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4078	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2933523	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1850423	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5583773	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2838466	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	19216528	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1937202	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	101251	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-2389	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2647861	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18604731	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1311714	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-1689	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2931834	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	16982922	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	320213	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	432672	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1597693	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1156	usd
CY2023Q1	ssii	Stock Issued During Period Value Accumulated Other Comprehensive Loss StockIssuedDuringPeriodValueAccumulatedOtherComprehensiveLoss	-2004320	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	347414	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6138541	usd
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	dei	Security Exchange Name SecurityExchangeName	NONE
CY2024Q2	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther		usd
	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q2	ssii	Stock Issued During Period Value Recapitalization1 StockIssuedDuringPeriodValueRecapitalization1	-4556208	usd
CY2023Q2	ssii	Stock Issued During Period Value Accumulated Other Comprehensive Loss StockIssuedDuringPeriodValueAccumulatedOtherComprehensiveLoss	742271	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1850423	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	821595	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5579695	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2838466	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	379608	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	310897	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	149215	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3248916	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2702556	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4064	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	902474	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	10626023	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3660476	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2632123	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9637	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	342501	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2094584	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10521468	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1488212	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	736006	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2900895	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	3771547	usd
	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	270149	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4118959	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1507552	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2775000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4450000	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	1688608	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	4963385	usd
	ssii	Proceeds From Accumulated Other Comprehensive Incomeloss ProceedsFromAccumulatedOtherComprehensiveIncomeloss	899917	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	101252	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8170061	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6239860	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11258363	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	26318	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-770657	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4080	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-157645	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7051927	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1351364	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7074165	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423062	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-02-04
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one for ten
	ssii	Working Capital Deficit WorkingCapitalDeficit	4900000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32010000.00	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2930000	usd
	ssii	Percentage Of General Surgery Procedures Constituted PercentageOfGeneralSurgeryProceduresConstituted	0.71	pure
CY2024Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	4450000	usd
CY2024Q2	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q2	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
	ssii	Accrued Interest Percentage AccruedInterestPercentage	0.07	pure
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss		usd
CY2023Q2	ssii	Stock Issued During Period Value Recapitalization StockIssuedDuringPeriodValueRecapitalization		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables		usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	ssii	Proceeds From Accumulated Other Comprehensive Incomeloss ProceedsFromAccumulatedOtherComprehensiveIncomeloss		usd
	us-gaap	Net Income Loss NetIncomeLoss	-5580000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001676163
CY2024Q2	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2000000	usd
CY2024Q2	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. The Company regularly evaluates estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates made by management.</p>
	ssii	Closing Rate Of Forigen Currency Transaction ClosingRateOfForigenCurrencyTransaction	INR 83.36 to one US$
	ssii	Average Rate Of Foriegn Currency Transaction AverageRateOfForiegnCurrencyTransaction	83.33 INR to one US$
CY2024Q2	us-gaap	Inventory Net InventoryNet	6443067	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its principal cash balance in United States financial institutions, where deposits are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company also maintains cash balances maintained with banks in India, where balances are insured by Deposit Insurance and Credit Guarantee Corporation of India (DICGC) to the extent of approximately US$ 6,100 per account and in the Bahamas, where deposits are insured by the Deposit Insurance Corporation of Bahamas insures deposits up to US$50,000 per account. As at June 30, 2024, deposits of $ 214,879 were in excess of overall insurance coverage limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q2	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	6100	usd
CY2024Q2	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	50000	usd
	us-gaap	Payments For Deposits PaymentsForDeposits	214879	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2602218	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1114006	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	578573	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	407601	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2023645	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706405	usd
	us-gaap	Depreciation Depreciation	170972	usd
	us-gaap	Depreciation Depreciation	310897	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4603800	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1901244	usd
CY2024Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	5265908	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2365013	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	9869708	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4266257	usd
CY2024Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	5265908	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	5619490	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5029650	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	327012	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	35919	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	5946502	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	5065569	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4501398	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3890017	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	4332081	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	4322444	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8833479	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8212461	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1295003	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901550	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3844064	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	577040	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	939150	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	939150	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6078216	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2417740	usd
CY2024Q2	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2000000	usd
CY2024Q2	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.45
CY2024Q2	us-gaap	Bank Overdrafts BankOverdrafts	7707534	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2024Q2	us-gaap	Deposits Deposits	5552203	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.05	pure
CY2024Q2	us-gaap	Other Assets OtherAssets	0	usd
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	65443337	shares
CY2024Q2	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	5000000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6544333	shares
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0001
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5000000	usd
CY2024Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10149232	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3350221	shares
CY2024Q2	ssii	Options To The Extent Vested Expire Term OptionsToTheExtentVestedExpireTerm	P5Y
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1829.25	usd
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2454.75	usd
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2223	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1474.17	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	404.68	usd
	ssii	Monthly Space Rent MonthlySpaceRent	194	usd
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16528	usd
	ssii	Lease Expiration Date LeaseExpirationDate	March 2030
CY2023Q2	us-gaap	Area Of Land AreaOfLand	21600	sqft
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12033	usd
CY2024Q2	us-gaap	Rental Properties RentalProperties	7000	usd
CY2024Q2	us-gaap	Loans Payable LoansPayable	1297410	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	1567559	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	ssii	Accrued Interest Percentage AccruedInterestPercentage	0.07	pure
CY2024Q2	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2000000	usd
CY2024Q2	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q2	ssii	Accrued Interest Percentage AccruedInterestPercentage	0.07	pure

Files In Submission

Name	View Source	Status
0001213900-24-076570-index-headers.html	Edgar Link	pending
0001213900-24-076570-index.html	Edgar Link	pending
0001213900-24-076570.txt	Edgar Link	pending
0001213900-24-076570-xbrl.zip	Edgar Link	pending
ea0213712-10q_ssinnova.htm	Edgar Link	pending
ea021371201ex31-1_ssinnova.htm	Edgar Link	pending
ea021371201ex31-2_ssinnova.htm	Edgar Link	pending
ea021371201ex32-1_ssinnova.htm	Edgar Link	pending
ea021371201ex32-2_ssinnova.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0213712-10q_ssinnova_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssii-20240630.xsd	Edgar Link	pending
ssii-20240630_cal.xml	Edgar Link	unprocessable
ssii-20240630_lab.xml	Edgar Link	unprocessable
ssii-20240630_pre.xml	Edgar Link	unprocessable
ssii-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSII
SS Innovations International, Inc. Stock $ssii

2024 Q3 Form 10-Q Financial Statement

#000121390024076570 Filed on September 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII SS Innovations International, Inc. Stock $ssii

2024 Q3 Form 10-Q Financial Statement

#000121390024076570 Filed on September 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII
SS Innovations International, Inc. Stock $ssii